Dr. A. CORNELIS anatomopathologie
ActiveDr. A. CORNELIS anatomopathologie has been active since 2004 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €213k and a net result of €1k. Equity is shrinking by ~6.5% per year across the filed fiscal years. Its solvency ranks better than 55% of 19904 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2024
86
/ 100
Excellent▼ -8 vs 2023
The score combines four axes. Every signal that weighs is under Signals.
Axes · tick = 2023
Profitability3▼-42
Solvency100=
Growth58=
Stability100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €18k at 30 days acceptable
Liquidity ample (current ratio 4.12 against 3.48 in 2023), and 28.2% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
lowers risk · Growing equity
Equity grew over 2022-2024. Profits are largely retained rather than distributed.
NBB · annual accounts 2024Equity per financial year
18192021222324
2018 to 2024 · latest year €213k
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 30-07-2025, 1 day ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
not confirmed
2024
1 d early
2023
68 d late
2022
92 d late
2021
31 d late
2020
90 d late
2019
17 d early
← before the deadline
after the deadline →
Financials · fiscal year 2024, micro schema
Equity
€213k▲ 0.5%
2023 · €211k
2018: €297k
2019: €320k
2020: €346k
2021: €378k
2022: €192k
2023: €211k
2018 → 2024
Total assets
€296k▼ 4.0%
2023 · €308k
2018: €438k
2019: €439k
2020: €419k
2021: €435k
2022: €309k
2023: €308k
2018 → 2024
Net result
€1k▼ 94.3%
2023 · €19k
2018: €-6k
2019: €24k
2020: €26k
2021: €32k
2022: €7k
2023: €19k
2018 → 2024
Working capital
€218k▲ 0.5%
2023 · €217k
2018: €150k
2019: €134k
2020: €173k
2021: €230k
2022: €190k
2023: €217k
2018 → 2024
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20202021202220232024Trend
Equity€346k-€378k▲ 9.2%€192k▼ 49.1%€211k▲ 10.0%€213k▲ 0.5%
Operating result€39k-€48k▲ 22.7%€14k▼ 70.0%€35k▲ 146%€6k▼ 82.6%
Net result€26k-€32k▲ 24.4%€7k▼ 76.6%€19k▲ 158%€1k▼ 94.3%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2024; 2024 is 83% below 2023 and is the lowest year so far.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €296k
Fixed assets
€8k▲ 87.6%
Current assets
€288k▼ 5.4%
Equity and liabilities €296k
Equity
€213k▲ 0.5%
Debt
€83k▼ 13.9%
The debt ratio falls from 31.4% to 28.2%: equity grows while debt is paid down.
Key figures and ratios
EBITDA
€8k▼
2023 · €37k
Cash flow
€3k▼
2023 · €21k
Solvency
71.8%▲
2023 · 68.6%
Current ratio
4.12▲
2023 · 3.48
Quick ratio
4.12▲
2023 · 3.48
Debt / equity
0.39▼
2023 · 0.46
ROE
0.5%▼
2023 · 9.1%
ROA
0.4%▼
2023 · 6.2%
Interest coverage
4.68▼
2023 · 6.86
Debt
€83k▼
2023 · €97k
Debt ≤ 1 year
€70k▼
2023 · €87k
Income taxes
€4k▼
2023 · €11k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2024 against 2023
Balance sheet
Code20232024
Assets
Total assets20/58€308k€296k▼
Fixed assets21/28€4k€8k▲
Tangible fixed assets22/27€4k€8k▲
Plant, machinery and equipment23€158€3k▲
Other tangible fixed assets26€4k€6k▲
Current assets29/58€304k€288k▼
Amounts receivable within one year40/41€2k€8k▲
Other amounts receivable41€2k€8k▲
Cash at bank and in hand54/58€284k€275k▼
Deferred charges and accrued income490/1€17k€5k▼
Equity and liabilities
Total equity and liabilities10/49€308k€296k▼
Equity10/15€211k€213k▲
Contributions10/11€19k€19k=
Reserves13€193k€194k▲
Distributable reserves133€193k€194k▲
Amounts payable17/49€97k€83k▼
Amounts payable within one year42/48€87k€70k▼
Trade debts44€3k€5k▲
Suppliers440/4€3k€5k▲
Other amounts payable47/48€84k€65k▼
Accrued charges and deferred income492/3€10k€14k▲
Income statement
Code20232024
Non-recurring operating income76A-€22k
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€1k€1k▼
Other operating charges640/8€810€895▲
Gross operating margin9900€38k€8k▼
Operating profit (loss)9901€35k€6k▼
Financial income75/76B€109€190▲
Recurring financial income75€109€190▲
Financial charges65/66B€5k€2k▼
Recurring financial charges65€5k€2k▼
Profit (loss) for the period before taxes9903€30k€5k▼
Income taxes67/77€11k€4k▼
Profit (loss) for the period9904€19k€1k▼
Profit (loss) for the period to be appropriated9905€19k€1k▼
Appropriation of the result
Profit (loss) to be appropriated9906€19k€1k▼
Transfer to equity691/2€19k€1k▼
To other reserves6921€19k€1k▼
The notes to these accounts (9 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
2025
30-07
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
07-10
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 68 days late
2023
31-12
Financial
Equity above €200kEq €211k ▲10%
5 profitable years in a row build equity to €211k.
31-10
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 92 days late
2022
31-08
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 31 days late
2021
31-12
Financial
Highest result since 2018net €32k ▲24.4%
Operating result €48k, net result €32k, both a record.
29-10
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 90 days late
2020
14-07
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema
2019
31-12
Financial
Back to profitnet €24k
Net result €24k after one loss-making year.
30-08
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema · 30 days late
2018
23-08
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema · 23 days late
2017
31-08
NBB filing
Annual accounts filed
fiscal year 2016 · micro schema · 31 days late
2016
31-08
NBB filing
Annual accounts filed
fiscal year 2015 · abbreviated schema · 31 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
4 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Hoegaarden · 1 establishment unit since 2018
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Sint-Niklaasstraat 273321 HoegaardenGround area
7,661 m²
Building footprint
6,311 m²
Volume, LiDAR
76,958 m³
2 parcels, Flanders · tallest building 25.2 m, ±4 floors. Linked by address, not a title deed.
1 establishment unit
RZ Tienen
since 20182.332.101.912
2 parcels
Flanders
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 24593G0005/00S000 | Flanders | 6,976 m² | 1 · 6,061 m² | 25.1 m · 4 fl. |
| 24087E0549/00P000 | Flanders | 684 m² | 1 · 251 m² | 9.8 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
1 of these parcels carry protected heritage (source: regional heritage registers, Onroerend Erfgoed / patrimoine.brussels).
Similar companies · same sector, comparable size
Cabinet d'Expertise Médicale du Dr. van LIEROP
BE 0883.091.661
Sprimont · Eq €213k
Dr. Laura Mertens Dermatologie
BE 0794.577.478
Affligem · Eq €213k
DR. GAETAN CLAEYS ANESTHESIE-INTENSIEVE ZORGEN
BE 0794.360.912
Damme · Eq €213k
Anesthesie Docteur Sophie Thomas
BE 0533.887.505
Genappe · Eq €212k
DOKTER HANNELORE VAN DER VEKEN - GYNAECOLOGIE
BE 0741.761.176
Nazareth-De Pinte · Eq €212k
Of 16,604 companies in sector 86220 we hold annual accounts for 7,961. 6,642 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded02-07-2004
Fiscal year end31-12
Activities, NACEBEL
86220Specialist medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 21 filingsAddress and cadastre registers
Data from official sources, last processed on 16-09-2026. Scores and ratios are computed by Checked and are not a credit decision.